Table I.
Measurement | Herbst brachyfacial mean | SD | Herbst mesofacial mean | SD | Control mean | SD | P value |
---|---|---|---|---|---|---|---|
Age (y) | 13.36 | 0.58 | 12.74 | 0.85 | 13.73 | 0.82 | 0.03* |
Sex | 4 female, 4 male | - | 7 female, 1 male | 6 female, 5 male | - | - | |
Phase 1 duration (mo) | 7.21 | 1.41 | 7.93 | 2.23 | - | - | 0.46 |
Phase 2 duration (mo) | 20.38 | 3.92 | 19.25 | 4.40 | - | - | 0.60 |
Total treatment time (mo) | 27.59 | 4.31 | 27.18 | 5.78 | 22.81 | 8.69 | 0.25 |
ANB (°) | 6.0 | 0.9 | 5.4 | 1.4 | 3.9 | 2.2 | 0.03† |
Pog-N perp (mm) | −2.4 | 4.4 | −3.8 | 6.1 | −3.8 | 3.6 | 0.83 |
Gonial angle (Co-Go-Me) (°) | 118.1 | 3.9 | 127.1 | 5.6 | 122.8 | 4.9 | 0.003‡ |
FMPA (°) | 18.3 | 4.1 | 27.9 | 1.4 | 24.5 | 5.0 | 0.0002‡ |
Class II molar relationship (mm) | 6.6 | 1.5 | 6.3 | 1.5 | 4.6 | 1.4 | 0.01§ |
Significant difference at P<0.05 for Herbst mesofacial vs control group only;
Significant difference at P<0.05 for Herbst brachyfacial vs control group only;
Significant difference at P<0.05 for Herbst brachyfacial group vs Herbst mesofacial and control group;
Significant difference at P<0.05 for Herbst brachyfacial group and Herbst mesofacial vs control group.